UK-based SME offers its novel fluorescent molecular imaging probe technology to companies using fluorescent imaging in their products and workflows under a technical cooperation
A UK-based SME has developed novel fluorescent molecular imaging technology for biological and medical science research. They are offering their conjugated polymer nanoparticles to companies that are using fluorescent probes in their products, services or workflows to reach new markets and further develop their technology. It is envisaged that the partnership will take the form of a technical cooperation agreement.
The UK-based SME is looking to partner with companies who are using, or are looking to use, fluorescent imaging probes in their products or systems. The UK-based SME will offer their unique conjugated polymer nanoparticles to partner companies to incorporate into their systems, products and workflows. They would expect feedback from the partner companies in relation to the performance of the conjugated polymer nanoparticles in their products and workflows in order to inform further development of the existing conjugated polymer nanoparticles and introduction of new product lines. It is envisaged that the partnership will take the form of a technical cooperation agreement although other partnerships will be considered dependent on circumstances.
The use of fluorescent probes is an essential part of biological science research and provides a vital tool for medical research. They are used to detect and monitor molecules of interest within cells and tissues among other applications. However, the technology currently used has not developed much since the 1980's and has several flaws that limit effectiveness. This includes limited brightness, photobleaching, and poor stability of current fluorescent probes, which restricts sensitivity. A UK-based SME has developed a novel fluorescent molecular imaging probe technology that overcomes these limitations. They have developed conjugated polymer nanoparticles containing a semiconductor light emitting polymer core, encapsulated within a surfactant. These particles are brighter and more stable than currently used technology such as fluorophores and quantum dots, making them more sensitive. They are also non-toxic so can be used in live cell and tissue imaging as well as in in vivo experiments. These particles can also incorporate a magnetic core enabling additional functions such as sample purification. The particles can be used in existing methodologies (fluorescent microscopy, flow cytometry, immunohisto/cytochemistry, Enzyme-Linked Immunosorbent Assay (ELISA), Rapid Diagnostic Tests, lateral flow diagnostics etc.) with no changes to protocols needed. The UK-based SME is looking to further develop this technology and enter new markets. They are therefore offering their conjugated polymer nanoparticles to companies that are using or plan to use existing fluorescent imaging probes in their products or services and workflows. The SME would like feedback from partner companies on the use of their nanoparticles in products and workflows so they can further adapt and develop the technologies to add to their portfolio. It is envisaged that the partnership will take the form of a technical cooperation but other partnerships will be considered depending on individual circumstances.
Advantages and innovations
The UK-based SME's novel conjugated polymer nanoparticle imaging probes have the following advantages: 1. High degree of photostability preventing loss of signal due to photobleaching. 2. Highly specific targeting. 3. Non-toxic enabling normal cell and tissue function to be studied. 4. Compatible with current molecular detection systems (fluorescent microscopy, flow cytometry, immunohisto/cytochemistry, ELISA, Rapid Diagnostic Tests, lateral flow diagnostics etc.) 5. Can be used in vivo and in vitro with no changes to existing, established protocols. 6. Magnetic core capability enables modal imaging and magnetic sample purification. 7. 1400x brighter than existing alexa fluorophores, 200x brighter than Quantum Dots. 8. Four wavelengths can be produced at scale with a further four wavelengths in development and will be available in 2019.
Already on the market
Intellectual Property Rights (IPR)
Secret Know-how,Patents granted
Register your interest
How it works
- Tell us about yourself
- We’ll discuss with you
- We put the right partners in touch
EEN help you find the right partner, rather than you going it alone.
Our role is to review and collate the most suitable submissions, and then send them to the client who posted the opportunity. We consult with you, and the client, to make the process professional and easy.
These are live opportunities. Your registration of interest on the site is just like a professional approach to a business at a networking event. To stand the best chance of success, make your submission really sing. Sell why the client who posted the opportunity should work with you. Excite them. Ask questions. Try and avoid copy and pasting words from elsewhere.
Once the client has chosen their partner, we'll introduce them over email and keep in touch with both parties to see how it's going. Sometimes things progress quickly. Sometimes because of changing priorities for either party, things progress slowly, but you never know - your next big business break could start right here.
First we need to check you’re human.
Thank you for verifying your email. We have sent you a confirmation email containing a 6 digit verification code to unlock the form below